$65.2 Million is the total value of HealthInvest Partners AB's 10 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 73.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AET | New | AETNA INC NEW | $11,352,000 | – | 89,000 | +100.0% | 17.41% | – |
| ABC | Buy | AMERISOURCEBERGEN CORP | $11,151,000 | +33.3% | 126,000 | +17.8% | 17.10% | +121.8% |
| GILD | Buy | GILEAD SCIENCES INC | $7,947,000 | -1.8% | 117,000 | +3.5% | 12.19% | +63.4% |
| ANIK | Buy | ANIKA THERAPEUTICS INC | $7,888,000 | -8.4% | 181,573 | +3.2% | 12.10% | +52.4% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $7,701,000 | -9.0% | 85,612 | -22.9% | 11.81% | +51.4% |
| MCK | Sell | MCKESSON CORP | $7,561,000 | -5.6% | 51,000 | -10.5% | 11.59% | +57.2% |
| OSIR | New | OSIRIS THERAPEUTICS INC NEW | $5,473,000 | – | 1,140,222 | +100.0% | 8.39% | – |
| GNCIQ | GNC HLDGS INC | $3,113,000 | -33.3% | 422,955 | 0.0% | 4.77% | +11.0% | |
| ACHN | New | ACHILLION PHARMACEUTICALS IN | $2,096,000 | – | 497,807 | +100.0% | 3.21% | – |
| ICCC | IMMUCELL CORP | $931,000 | -7.1% | 168,323 | 0.0% | 1.43% | +54.7% | |
| ATEC | Exit | ALPHATEC HOLDINGS INC | $0 | – | -426,855 | -100.0% | -1.26% | – |
| ELOS | Exit | SYNERON MEDICAL LTD | $0 | – | -706,107 | -100.0% | -5.46% | – |
| GTS | Exit | TRIPLE-S MGMT CORPcl b | $0 | – | -364,156 | -100.0% | -6.94% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -136,100 | -100.0% | -7.38% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -56,300 | -100.0% | -7.46% | – |
| TARO | Exit | TARO PHARMACEUTICAL INDS LTD | $0 | – | -78,905 | -100.0% | -7.65% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -117,800 | -100.0% | -7.81% | – |
| SUPN | Exit | SUPERNUS PHARMACEUTICALS INC | $0 | – | -538,241 | -100.0% | -12.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-04-28
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
| CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ANTHEM INC | 12 | Q4 2017 | 14.3% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
| ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.